Erythrocyte Autoantibody Positivity in Serological Cross-matching

J Coll Physicians Surg Pak. 2020 May;30(5):485-489. doi: 10.29271/jcpsp.2020.05.485.

Abstract

Objective: To investigate the erythrocyte autoantibody positivity detected in the serological cross-matching (XM), and its possible effects on salient hemogram parameters.

Study design: A descriptive study.

Place and duration of study: Balıkesir Atatürk City Hospital's Blood Transfusion Centre, Faculty of Medicine, Department of Anesthesiology and Reanimation, Balıkesir University, Turkey, from 2017 to 2018.

Methodology: Erythrocyte autoantibody positivity, which was detected in the traditional serological cross-matching for a pre-transfusion laboratory test were analysed retrospectively. Later, hemogram changes in the previous (no erythrocyte autoantibodies) and following (erythrocyte autoantibodies present) transfusions were investigated using statistical methods.

Results: Erythrocyte autoantibody positivity rate was 10.16% (342/3,365). There was no statistically significant difference in the increase of hemoglobin, hematocrit, and red blood cell between the period when erythrocyte autoantibodies were detected or not, (p = 0.27, 0.13, and 0.09, respectively).

Conclusion: Erythrocyte autoantibodies positivity found on routine cross-match exmination, which must be considered together with parameters such as previous transfusion history, other pre-transfusion laboratory test results, and clinical presentation and management. Key Words: Transfusion, Erythrocye autoantibody, Alloantibody, Hemogram, Cross-matching.

MeSH terms

  • Autoantibodies
  • Blood Grouping and Crossmatching*
  • Erythrocytes*
  • Retrospective Studies
  • Turkey

Substances

  • Autoantibodies